Manufacturer record
Navkar Lifesciences: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
12 batches manufactured by Navkar Lifesciences (Himachal Pradesh) were declared Not of Standard Quality between October 2021 and January 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
12 records linked to Navkar Lifesciences in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Povidone-Iodine Ointment USP | OG5019AMfg 2025-07 · Exp 2027-06 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Jan 2026 |
| Paracetamol | TF3059AMfg 2023-06 · Exp 2026-05 | Dissolution TestDissolution | SDT&RL, BhubaneswarState lab | Jan 2026 |
| Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup(Broxin-SB Expectorant) | LA5029AMfg 2025-01 · Exp 2026-12 | ContentOther | Drugs Testing Laboratory, Chennai-06State lab | Dec 2025 |
| Povidone-Iodine Ointment USP | OI4004AMfg 2024-09 · Exp 2026-08 | Assay of Povidone Iodine calculated as available IodineAssay | RDTL, ChandigarhCDSCO lab | Mar 2025 |
| Itraconazole Capsules B.P. 100 mg | CH2006AMfg 2022-08 · Exp 2024-07 | DissolutionDissolution | RDTL GuwahatiState lab | Jan 2023 |
| Cuprox-10 (Isoxsuprine Hydrochloride Tablets I.P. 10 mg) | G-153/4014Mfg 2021-09 · Exp 2023-08 | DissolutionDissolution | CDL KolkataCDSCO lab | Jan 2023 |
| Ofloxacin & Ornidazole Tablets IP | TK0034AMfg 2020-11 · Exp 2022-10 | DissolutionDissolution | RDTL GuwahatiCDSCO lab | Jul 2022 |
| Ofloxacin & Ornidazole Tablets IP | TB1030AMfg 2021-02 · Exp 2023-01 | DissolutionDissolution | CDL KolkataCDSCO lab | Jul 2022 |
| Ofloxacin & Ornidazole Tablets IP | TB1045AMfg 2021-02 · Exp 2023-01 | Dissolution & AssayAssay | CDL KolkataCDSCO lab | Jul 2022 |
| Pantoprazole Gastro-Resistant Tablets IP | TF1037AMfg 2021-06 · Exp 2022-11 | DissolutionDissolution | CDTL ChennaiCDSCO lab | May 2022 |
| Pantoprazole Gastro- Resistant Tablets IP | TF1036AMfg 2021-06 · Exp 2022-11 | DissolutionDissolution | CDTL ChennaiCDSCO lab | Jan 2022 |
| Ofloxacin and Ornidazole Tablets I.P. | TI0005AMfg 2020-09 · Exp 2022-08 | DissolutionDissolution | RDTL GuwahatiState lab | Oct 2021 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.